Omnicell - Upgrades

Forecast Recompete Updated

Agency
Solicitation expected
Estimated value
$25,000 to $250,000
Set-aside
No set-aside

Forecast facts

Incumbent contract
Anticipated award
NAICS code
339112 Surgical and Medical Instrument Manufacturing
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Indian Health Service is recompeting procurement of controlled substance medication cabinets with perpetual inventory capabilities, a Central Pharmacy Manager system for inventory tracking, and anesthesia workstation annual service support for its Anadarko and Carnegie sites, with solicitation release estimated for December 1, 2026, and award targeted for March 1, 2027. The procurement is unrestricted (NAICS 339112, Surgical and Medical Instrument Manufacturing) and carries an estimated award value between $25,000 and $250,000.

Place of performance includes the Anadarko and Carnegie Indian Health Service sites. Points of contact are MaryAnn Yocham, Contract Specialist, at maryann.yocham@ihs.gov or 405-951-6043, and Troy Zapata, Clinical Staff Pharmacist, at troy.zapata@ihs.gov.

The recompeted award is delivery order 36F79723D0073-75H71126F80039, initially awarded to Omnicell, Inc. on April 20, 2026, for approximately $288,000 in medication management and pharmacy automation solutions under the GSA Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A), with performance in Lawton, Oklahoma and a completion date of December 31, 2026.

Forecast text

Controlled Substance Medication cabinet and perpetual inventory capabilities required for Anadarko and Carnegie sites. Central Pharmacy Manager needed for LIH inventory. Also addition of anesthesia workstation's yearly service.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast